NCT00667264

Brief Summary

Research study to determine if putting local anesthetic-or numbing medication-through one or two tiny tube(s) placed next to the nerves that go to an amputated limb will decrease phantom limb and/or stump pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2008

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 24, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 28, 2008

Completed
5 months until next milestone

Study Start

First participant enrolled

October 1, 2008

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2011

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
Last Updated

June 28, 2012

Status Verified

June 1, 2012

Enrollment Period

2.3 years

First QC Date

April 24, 2008

Last Update Submit

June 26, 2012

Conditions

Keywords

painphantom limbstump paincatheternerve blockperipheral nerve blockucsdPost-amputation phantom limb or stump pain

Outcome Measures

Primary Outcomes (1)

  • Primary analysis will compare the two treatment groups for the phantom limb/stump pain change from baseline to 4 weeks following the initial catheter placement

    Week 4

Secondary Outcomes (3)

  • Physical Functioning · Brief Pain Inventory

    pre-intervention, then days 1, 3, 8, 28, 84, and 365

  • Nervous System Reorganization [if patient elected to participate in the MRI procedures] · MRI procedure

    pre-intervention; and then 8 and 28 days post-intervention

  • Pain · 11-point numeric rating scale of pain intensity · Usage of baseline and rescue analgesics in previous 24 hours · Patient Global Impression of Change scale

    Day 8, Day 28, Month 12

Study Arms (2)

Active

ACTIVE COMPARATOR

3-7 days of perineural local anesthetic infusion

Procedure: perineural ropivacaine

Placebo

PLACEBO COMPARATOR

3-7 days of perineural normal saline infusion

Procedure: perineural ropivacaine

Interventions

Subjects will be randomized to one of two groups: ropivacaine 0.4% or normal saline (placebo). The basal rate will be set at 7 mL/h.

ActivePlacebo

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • previous upper or lower limb amputation including at least one metacarpal or metatarsal bone, respectively
  • age 18 years or older
  • phantom limb and/or stump pain described as at least a 2 on the NRS for the previous week \[and pain occurring on a weekly basis over the previous month\]
  • willing to have an ambulatory perineural infusion for 6 days
  • willing to avoid additional "new" analgesic interventions from 4 weeks prior to at least 4 weeks following catheter placement, and preferably to 6 months following catheter placement
  • the availability of a "caretaker" who will transport the subject home following the procedure and remain with the subject for the first night of the infusion

You may not qualify if:

  • known hepatic or renal insufficiency
  • allergy to the study medications
  • possessing a contraindication to perineural catheter placement or perineural local anesthetic infusion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCSD Medical Center

San Diego, California, 92103, United States

Location

MeSH Terms

Conditions

Phantom LimbPain

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPain, PostoperativePostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

  • Brian Ilfeld, M.D., M.S.

    University of California, San Diego

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, In Residence

Study Record Dates

First Submitted

April 24, 2008

First Posted

April 28, 2008

Study Start

October 1, 2008

Primary Completion

January 1, 2011

Study Completion

December 1, 2011

Last Updated

June 28, 2012

Record last verified: 2012-06

Locations